Globus Medical (GMED) Long-Term Deferred Tax (2016 - 2025)
Globus Medical (GMED) has disclosed Long-Term Deferred Tax for 15 consecutive years, with $218.2 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax rose 131.65% year-over-year to $218.2 million, compared with a TTM value of $218.2 million through Dec 2025, up 131.65%, and an annual FY2025 reading of $218.2 million, up 131.65% over the prior year.
- Long-Term Deferred Tax was $218.2 million for Q4 2025 at Globus Medical, down from $232.4 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $275.9 million in Q2 2025 and bottomed at $7.3 million in Q3 2023.
- Average Long-Term Deferred Tax over 5 years is $67.6 million, with a median of $39.9 million recorded in 2022.
- The sharpest move saw Long-Term Deferred Tax plummeted 83.64% in 2023, then surged 1416.0% in 2025.
- Year by year, Long-Term Deferred Tax stood at $24.5 million in 2021, then skyrocketed by 99.42% to $48.8 million in 2022, then plummeted by 78.12% to $10.7 million in 2023, then surged by 781.61% to $94.2 million in 2024, then soared by 131.65% to $218.2 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for GMED at $218.2 million in Q4 2025, $232.4 million in Q3 2025, and $275.9 million in Q2 2025.